Company profile for NEC Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We utilize a broad range of IT and AI technologies in various drug development activities. NEC develops cancer vaccines using AI technologies. This acquisition is integral for enhancing the resources and capabilities that support the development of its individualized immunotherapy pipelines. NEC will maintain its focus on drug discovery, while NEC OncoImmunity AS continues its neoantigen prediction services.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
7-1, Shiba 5-chome Minato-ku, Tokyo 108-8001
Telephone
Telephone
+81-3-3454-1111
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.expresspharma.in/nec-and-chugai-pharmaceutical-use-ai-to-reduce-drug-combination-prediction-time-for-cancer-treatments/

EXPRESSPHARMA
19 Jun 2025

https://www.businesswire.com/news/home/20211122006339/en

BUSINESSWIRE
22 Nov 2021

https://www.nec.com/en/press/202010/global_20201006_03.html

PRESSRELEASE
06 Oct 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty